Effectiveness and safety of PCSK9 inhibitors in real-world clinical practice. An observational multicentre study. The IRIS-PCSK9I study.
Blanco-Ruiz M, Amaya-Pascasio L, de Torres Chacón R, Álvarez Soria MJ, Arjona-Padillo A, Carrillo Bailén MM, Milán Pinilla R, Pérez Ortega I, Sánchez Rodríguez B, Andrade Zumárraga L, Valverde Moyano R, Payán Ortiz M, Castillo Fernández AM, Del Toro Pérez C, González Bustos P, Agüera Morales E, Sánchez López P, Hidalgo Martín B, Roa Chamorro R, Fernández Pérez J, Mejías Olmedo MV, Martínez-Sánchez P.
Blanco-Ruiz M, et al. Among authors: del toro perez c.
Atheroscler Plus. 2021 Oct 3;45:32-38. doi: 10.1016/j.athplu.2021.08.009. eCollection 2021 Nov.
Atheroscler Plus. 2021.
PMID: 36643997
Free PMC article.